Update on the use of hydroxyurea therapy in sickle cell disease. Blood 2014 Dec 18;124(26):3850-7; quiz 4004
Date
10/08/2014Pubmed ID
25287707Pubmed Central ID
PMC4271176DOI
10.1182/blood-2014-08-435768Scopus ID
2-s2.0-84919464653 (requires institutional sign-in at Scopus site) 79 CitationsAuthor List
Wong TE, Brandow AM, Lim W, Lottenberg RAuthor
Amanda Brandow DO Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAnemia, Sickle Cell
Anti-Inflammatory Agents, Non-Steroidal
Antisickling Agents
Child, Preschool
Female
Hospitalization
Humans
Hydroxyurea
Male
Observational Studies as Topic
Randomized Controlled Trials as Topic
Treatment Outcome
Young Adult
beta-Thalassemia
